Drug companies to collaborate on Alzheimer's disease | Opensource.com

Drug companies to collaborate on Alzheimer's disease

Image by : 

opensource.com

Get the newsletter

Join the 85,000 open source advocates who receive our giveaway alerts and article roundups.

The rising cost of development and research is making drug companies turn to each other for help. Rival companies that include Pfizer, AstraZeneca, and Roche plan on sharing clinical data in a standard format. But this isn't the first time we've seen pharmaceutical companies start to share data.

"...Coordinated by the U.S.-based Coalition Against Major Diseases, marks the latest in an intensifying series of research initiatives by industry to override competitive concerns and open up their findings to others as they struggle to reduce costs and boost the speedy launch of medicines."

Read more about this project over at TheStreet: Drug Firms Team on Alzheimer's.

Let's hope we start to see more collaboration for a cure--solving the world's biggest problems the open source way.

Thanks to Mike Esser for sending TheStreet article our way.

See a similar article posted on WSJ.com Drug Makers Share Data From Failed Trials.

About the author

Jason Hibbets
Jason Hibbets - Jason Hibbets is a senior community architect at Red Hat which means he is a mash-up of a community manager and project manager for Opensource.com. He primarily works with the DevOps Team and Open Organization community. He is the author of The foundation for an open source city and has been with Red Hat since 2003. Follow him on Twitter: @jhibbets for a fun and shareable feed of his open source (and other)... more about Jason Hibbets